EUVIMEDEUVIMED entdecken
Crossref

Assessing the risk of gastrointestinal perforation associated with COVID-19: a self-controlled case series study

Takayuki Okura iD, Sachiko Tanaka-Mizuno iD, Toshiki Fukasawa iD, Satomi Yoshida iD, Koji Kawakami iD

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwae448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Takayuki Okura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan. Hauptthemen laut MEDLINE: COVID-19, Intestinal Perforation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although some case reports have reported gastrointestinal perforation after COVID-19, epidemiologic studies investigating this association are scarce. We aimed to assess the risk of gastrointestinal perforation associated with COVID-19. We conducted a self-controlled case series (SCCS) study using a Japanese nationwide, large-scale claims database. We identified patients diagnosed with COVID-19 between March 2020 and October 2022 who had undergone surgery for gastrointestinal perforation. Conditional Poisson regression was used to estimate the incidence rate ratio (IRR) and 95% confidence intervals (CIs) of gastrointestinal perforation during the 4-week risk period compared with the control period. Our SCCS study included 276 patients. The IRR for gastrointestinal perforation was 6.62 (95% CI, 3.52-12.47) for the first week, 3.27 (95% CI, 1.51-7.09) for the second week, and 1.45 (95% CI, 0.63-3.33) for the third and fourth weeks following COVID-19. The risk was lower in female patients than in male patients. In a subgroup analysis, the results were consistent regardless of age. This study suggests a significant association between COVID-19 and gastrointestinal perforation, particularly during the first 2 weeks. These findings highlight the need to recognize COVID-19 as a risk factor for gastrointestinal perforation. Trial registration: This research did not undergo prior registration in an independent registry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Intestinal PerforationHumansFemaleMaleMiddle AgedAgedJapanAdultSARS-CoV-2Risk FactorsAged, 80 and overIncidenceRisk Assessment

Stichwörter der Autor:innen

COVID-19gastrointestinal perforationreal-world dataself-controlled case series study

Autor:innen und Institutionen

  • Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan.
  • Laboratory of Epidemiology and Prevention, Kobe Pharmaceutical University, Kobe 658-8558, Japan.
  • Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan.
  • Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

ORCID-Profile: Takayuki Okura, Sachiko Tanaka-Mizuno, Toshiki Fukasawa, Satomi Yoshida, Koji Kawakami

Zitieren

APA

Okura, T., Tanaka-Mizuno, S., Fukasawa, T., Yoshida, S., & Kawakami, K. (2025). Assessing the risk of gastrointestinal perforation associated with COVID-19: a self-controlled case series study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae448

Vancouver

Okura T, Tanaka-Mizuno S, Fukasawa T, Yoshida S, Kawakami K. Assessing the risk of gastrointestinal perforation associated with COVID-19: a self-controlled case series study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwae448

BibTeX
@article{Okura2025,
  author = {Okura, Takayuki and Tanaka-Mizuno, Sachiko and Fukasawa, Toshiki and Yoshida, Satomi and Kawakami, Koji},
  title = {Assessing the risk of gastrointestinal perforation associated with COVID-19: a self-controlled case series study},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwae448}
}
Kostenlos starten →